Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263

Article  PubMed  Google Scholar 

Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P (2023) Cancer incidence estimates for 2022 & projection for 2025: result from national cancer registry programme, India. Indian J Med Res 156(4&5) p 598–607. https://doi.org/10.4103/ijmr.ijmr_1821_22

Mathur P et al (2020) Cancer Statistics, 2020: Report from national cancer registry programme. India. JCO Glob Oncol 6:1063–1075

Article  PubMed  Google Scholar 

Arnold M et al (2022) Current and future burden of BC: Global statistics for 2020 and 2040. Breast 66:15–23

Article  PubMed  PubMed Central  Google Scholar 

Jitariu AA et al (2017) Triple negative BC: the kiss of death. Oncotarget 8(28):46652–46662

Article  PubMed  PubMed Central  Google Scholar 

Yeo SK, Guan JL (2017) BC: Multiple subtypes within a tumor? Trends Cancer 3(11):753–760

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mittal S, Brown NJ, Holen I (2018) The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn 18(3):227–243

Article  PubMed  CAS  Google Scholar 

Gogia A et al (2019) Clinicopathologic characteristics and treatment outcomes of patients with up-front metastatic BC: single-center experience in India. J Glob Oncol 5:1–9

PubMed  Google Scholar 

Malhotra GK et al (2010) Histological, molecular and functional subtypes of BCs. Cancer Biol Ther 10(10):955–60

Article  PubMed  PubMed Central  Google Scholar 

Schettini F et al (2020) HER2-enriched subtype and pathological complete response in HER2-positive BC: a systematic review and meta-analysis. Cancer Treat Rev 84:101965

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhushan A, Gonsalves A, Menon JU (2021) Current State of Breast Cancer Diagnosis, Treatment, and Theranostics. Pharmaceutics. 13(5):723. https://doi.org/10.3390/pharmaceutics13050723

Tittmann J et al (2024) BC stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary. Discov Oncol 15(1):240

Article  PubMed  PubMed Central  Google Scholar 

Pollan M (2010) Epidemiology of BC in young women. BC Res Treat 123(Suppl 1):3–6

Google Scholar 

Zhu H, Dogan BE (2021) American joint committee on cancer’s staging system for bc, eighth edition: summary for clinicians. Eur J Breast Health 17(3):234–238

Article  PubMed  PubMed Central  Google Scholar 

Hammond ME et al (2010) American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and PRs in BC. J Oncol Pract 6(4):195–7

Article  PubMed  PubMed Central  Google Scholar 

Ahmad Fauzi MF, Wan Ahmad WSHM, Jamaluddin MF, Lee JTH, Khor SY, Looi LM, Abas FS, Aldahoul N (2022) Allred Scoring of ER-IHC Stained Whole-Slide Images for Hormone Receptor Status in Breast Carcinoma. Diagnostics (Basel). 12(12):3093. https://doi.org/10.3390/diagnostics12123093

Gordian-Arroyo AM, Zynger DL, Tozbikian GH (2019) Impact of the 2018 ASCO/CAP HER2 guideline focused update. American Journal of Clinical Pathology. 152(1):17–26

Article  PubMed  CAS  Google Scholar 

Dhanushkodi M, Sridevi V, Shanta V, Rama R, Swaminathan R, Selvaluxmy G, Ganesan TS (2021) Locally advanced breast cancer (LABC): real-world outcome of patients from cancer institute. Chennai. JCO Global Oncology. 7:767–81

Article  PubMed  Google Scholar 

Makki J (2015) Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol. 21(8):23–31. https://doi.org/10.4137/CPath.S31563.PMID:26740749;PMCID:PMC4689326

Article  Google Scholar 

Dubar S, Boukrid M, Bouquet de Joliniere J, Guillou L, Vo QD, Major A, Ali NB, Khomsi F, Feki A (2017) Paget’s breast disease: a case report and review of the literature. Front Sur 23(4):51

Article  Google Scholar 

Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52(1):108–18

Article  PubMed  CAS  Google Scholar 

Chowdhury AR, Swain SS, Mohanty SK, Banerjee B (2024) Androgen receptor influenced recurrence score correlation in hormone positive and HER2 negative breast cancer Indian patients: a comparative approach. Genome Integr. 4(15):e20240001. https://doi.org/10.14293/genint.15.1.001.PMID:39650747;PMCID:PMC11622693

Article  Google Scholar 

Parmar V, Koppiker CB, Dixit S (2021) Breast conservation surgery and oncoplasty in India - Current scenario. Indian J Med Res 154(2):221–228

Article  PubMed  PubMed Central  Google Scholar 

Agarwal G, Ramakant P (2008) BC Care in India: the current scenario and the challenges for the future. Breast Care (Basel) 3(1):21–27

Article  PubMed  Google Scholar 

Siddiqui B et al (2023) Molecular classification of breast carcinoma in a tertiary hospital of India: the recent trends. Indian J Surg Oncol 14(1):176–180

Article  PubMed  Google Scholar 

Rathod V et al (2021) First comprehensive report of clinicopathological profile of BC from Bihar. India. Indian J Surg Oncol 12(3):598–602

Article  PubMed  Google Scholar 

Jonnada PK et al (2021) Prevalence of molecular subtypes of BC in India: a systematic review and meta-analysis. Indian J Surg Oncol 12(Suppl 1):152–163

Article  PubMed  Google Scholar 

RoyChowdhury A, Dash HS, Samanta D et al (2024) Unmasking a novel frameshift BRCA 2 gene deleterious variant in TNBC setting: a possible candidate for poly (ADP-Ribose) polymerase inhibitors. Discov Med 1:170. https://doi.org/10.1007/s44337-024-00187-4

Article  Google Scholar